“In silico preliminary evaluation of bioactive compounds from five Unani drugs as potential SARS-CoV-2 inhibitors: IN SILICO EVIDENCE OF FIVE UNANI DRUGS AGAINST SARS-COV-2”, IJTK, vol. 23, no. 3, pp. 247–261, Mar. 2024, doi: 10.56042/ijtk.v23i3.1412.